Oppenheimer & CO Inc Soleno Therapeutics Inc Transaction History

Oppenheimer & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.14 - $0.23 $18,762 - $30,823	-134,016 Reduced 57.75%	98,054 $18,000
Q1 2022 May 12, 2022	SELL	$0.22 - $0.47 $15,135 - $32,335	-68,799 Reduced 22.87%	232,070 $52,000
Q4 2021 Feb 02, 2022	SELL	$0.41 - $0.91 $138,691 - $307,826	-338,271 Reduced 52.93%	300,869 $123,000
Q3 2021 Nov 12, 2021	BUY	$0.8 - $1.12 $4,455 - $6,237	5,569 Added 0.88%	639,140 $591,000
Q2 2021 Aug 03, 2021	BUY	$0.97 - $1.32 $406,489 - $553,160	419,061 Added 195.36%	633,571 $722,000
Q1 2021 May 10, 2021	BUY	$1.24 - $3.3 $190,757 - $507,662	153,837 Added 253.55%	214,510 $270,000
Q4 2020 Feb 11, 2021	BUY	$1.61 - $2.23 $719 - $996	447 Added 0.74%	60,673 $117,000
Q3 2020 Nov 13, 2020	SELL	$1.71 - $2.51 $1,872 - $2,748	-1,095 Reduced 1.79%	60,226 $151,000
Q2 2020 Aug 11, 2020	BUY	$1.77 - $4.23 $1,770 - $4,230	1,000 Added 1.66%	61,321 $136,000
Q1 2020 May 08, 2020	BUY	$1.64 - $3.85 $98,926 - $232,235	60,321 New	60,321 $144,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.